Navigation Links
Unigen Announces the Launch of Nivitol™ - Powerful New Anti-Aging Skin Care Ingredient

Unigen, Inc®, announces the launch of Nivitol™, a revolutionary breakthrough botanical anti-aging skin care ingredient. Unigen® has entered into multiple global license and supply agreements for Nivitol™ with some of the world's premiere manufacturers and marketers of quality skin care, makeup, fragrance and hair care products.

(PRWEB) May 7, 2010 -- Unigen, Inc®, announces the launch of Nivitol™, a revolutionary breakthrough botanical anti-aging skin care ingredient. Unigen® has entered into multiple global license and supply agreements for Nivitol™ with some of the world's premiere manufacturers and marketers of quality skin care, makeup, fragrance and hair care products.

Nivitol™ is a natural botanical alternative, derived from the novel plant extract Dianella ensifolia, and has been scientifically proven to visibly improve skin appearance. Nivitol™ contains a unique enzyme-blocking, or tyrosinase-inhibiting, agent that reduces skin pigmentation and safely lightens skin color without any adverse side effects often found with harsh chemicals. Clinical studies have shown Nivitol™ to be up to 20x more effective than the leading whitening agents such as hydroquinone and kojic acid. It has been thoroughly safety tested by independent third party institutes and has shown no adverse side effects. Additionally, Nivitol™ is extremely potent and can be effectively used at 10-50x lower concentrations than competitive whitening agents making it a cost-effective alternative. It is highly compatible in formulation with other skin care ingredients and can be used as an active agent in creams, lotions, gels, masks and other cosmetic products.

Pat Schneider, Unigen’s Chief Business Officer is extremely upbeat about the opportunities for Nivitol™. “The market for skin whitening, brightening and lightening is $9.8B strong and growing.” said Schneider. Over the last 5 years, this interest has spread to Europe and the US as part of a worldwide anti-aging trend and growing consumer demand for products that reduce dark spots and provide an “even tone” or “tone correcting” benefit resulting in more youthful looking skin.

“We are very excited to be working with several forward thinking giants in the cosmetic industry to provide safe, novel botanical ingredients like Nivitol™ and help develop superior anti-aging products” commented Schneider. Unigen’s scientific expertise in researching and discovering patented, clinically effective, natural ingredients has made significant advancements in the development of next generation skin care products.    Schneider added, “Nivitol™ is taking skin care science to the next level. With more new advancements in development, Unigen® will continue to be a leader in providing cutting edge ingredients that have the potential to positively affect the lives of millions.”

About Unigen
Unigen, Inc. is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.    


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Unigene Restates Policy on Analyst Reports
2. Stonegate Report About Unigene Laboratories Inc.
3. China Sky One Medical Announces Conference Call to Discuss First Quarter 2010 Results
4. Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Programs in the Developing World
5. Healthcare Data Solutions Announces New Executive Team Member
6. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
7. Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C
8. Angiotech announces exclusive distribution agreement with B. Braun for Angiotechs proprietary Quill(TM) SRS product line
9. PolyTouch Medical Ltd. Announces the Submission of a Premarket Application for PatchAssist - an Innovative Mesh Deployment and Placement Device for Laparoscopic Hernia Repair
10. Pieris Announces Positive Preclinical Data on c-Met Anticalin Drug Program
11. Scotland Announces New Life Science Leadership and Investments at BIO 2010
Post Your Comments:
Related Image:
Unigen Announces the Launch of Nivitol™ - Powerful New Anti-Aging Skin Care Ingredient 
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):